NFKB1 and non-small cell lung carcinoma: Co-delivery of Curcumin and Doxorubicin in nano-micelles for Human non-small cell lung cancer, A549, significantly reduced NF-κB and COX-2 activity and tumor growth in lung carcinoma tumor-bearing mice while reducing the side effects of Doxorubicin56.